biote Corp.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from biote Corp.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, is 2.3 times its market value (net debt). Lower than 98% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 6.5 times. Higher than 90% of Healthcare companies in United States.
- Profit Cash Ratio: Over the last 3 years, every $100 of reported profit came with $320 of operating cash. Higher than 88% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$320Over the last 3 years, every $100 of reported profit came with $320 of operating cash.
Higher than 88% of Healthcare companies in United States.
Self-Funding Ratio
6.5×Over the last 3 years its own operating cash covered its investment spending (capex) 6.5 times.
Higher than 90% of Healthcare companies in United States.
Cash Locked Ratio
$10For every $100 of sales, $10 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $8 tied up three years earlier.
Less money tied up than 79% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$103Sales grew 17% in 3 years; of every extra $100 of sales, $103 became extra profit.
Higher than 81% of Healthcare companies in United States.
Asset Productivity Ratio
+17% / -4%In 3 years sales changed by +17% while total assets changed by -4%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
5.6×Debt due within a year is covered 5.6 times by its yearly operating cash.
Higher than 81% of Healthcare companies in United States.
Cash Cushion Ratio
2.3× debtDebt, after subtracting cash, is 2.3 times its market value (net debt).
Lower than 98% of Healthcare companies in United States.
Tangible Assets Ratio
86%Of every $100 the company owns, $86 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 57% of Healthcare companies in United States.
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
biote Corp. owes $1.57 for every $1 it owns. Net profit rose 757% in the year to Dec 2025.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
7.8Investors pay $7.8 for every $1 of biote Corp.'s yearly profit, lower than 84% of Healthcare companies in United States.
P/B ratio
-0.56biote Corp.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$37 MThe total market value of all of biote Corp.'s shares at today's price (share price × number of shares), smaller than 77% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
Negativebiote Corp.'s net worth is negative ($66 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.57×biote Corp. owes $1.57 for every $1 it owns, so it owes more than it owns, higher than 95% of Healthcare companies in United States.
Dividend yield
Nonebiote Corp. does not currently pay a dividend.
Revenue growth
-3%Revenue fell 3% in the year to Dec 2025, and grew 5% a year on average over 3 years.
Profit growth
+757%Net profit rose 757% in the year to Dec 2025.
Profit margin
14.1%biote Corp. keeps $14 of every $100 of revenue as net profit.
Cash quality
1.3×Cash from biote Corp.'s business was 1.3× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
3.2×biote Corp.'s operating profit covered its interest costs 3.2 times in the year to Dec 2025.
Cash vs debt
Net debtbiote Corp. had $86 M more debt than cash (net debt) at Dec 2025.
Questions
What is biote Corp.'s P/E ratio?
Investors pay $7.8 for every $1 of biote Corp.'s yearly profit, lower than 84% of Healthcare companies in United States.
How much does biote Corp. owe compared with what it owns?
biote Corp. owes $1.57 for every $1 it owns, so it owes more than it owns, higher than 95% of Healthcare companies in United States.
Does biote Corp. pay a dividend?
No. biote Corp. does not currently pay a dividend.
Is biote Corp.'s revenue growing?
Revenue fell 3% in the year to Dec 2025, and grew 5% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.